TRPHARM   Report issue

For profit Phase 1
Founded: Istanbul Turkey (2013)

Organization Overview

First Clinical Trial
2016
NCT02667639
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

TRPHARM

Active Ingredients

Drugs in Phase 1 Trials (3)

bevacizumab (avastin) (1 trial)

rph-104 (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

sodium thiosulfate (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 4